PubMed

Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects.

Hawkins M, Gabriely I, Wozniak R, Reddy K, Rossetti L, Shamoon H.

Diabetes. 2002 Jul;51(7):2179-89.PMID: 12086948 [PubMed - indexed for MEDLINE]Related articlesFree article

Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes.

Hawkins M, Gabriely I, Wozniak R, Vilcu C, Shamoon H, Rossetti L.

Diabetes. 2002 Mar;51(3):606-14.PMID: 11872657 [PubMed - indexed for MEDLINE]Related articlesFree article

Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H.

Diabetologia. 1995 Mar;38(3):326-36.PMID: 7758880 [PubMed - indexed for MEDLINE]Related articles

Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

Diabetes. 2000 Jul;49(7):1209-18.PMID: 10909980 [PubMed - indexed for MEDLINE]Related articlesFree article

Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes.

Hawkins M, Tonelli J, Kishore P, Stein D, Ragucci E, Gitig A, Reddy K.

Diabetes. 2003 Nov;52(11):2748-58.PMID: 14578293 [PubMed - indexed for MEDLINE]Related articlesFree article

Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes.

Kishore P, Tonelli J, Koppaka S, Fratila C, Bose A, Lee DE, Reddy K, Hawkins M.

Diabetes. 2006 Jun;55(6):1761-8.PMID: 16731840 [PubMed - indexed for MEDLINE]Related articlesFree article

Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.

Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.

Diabetes. 1996 May;45(5):659-66. Erratum in: Diabetes 1996 Sep;45(9):1285. PMID: 8621019 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA.

Diabetes. 2003 Jun;52(6):1364-70.PMID: 12765945 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production.

Barzilai N, Hawkins M, Angelov I, Hu M, Rossetti L.

Diabetes. 1996 Oct;45(10):1329-35.PMID: 8826967 [PubMed - indexed for MEDLINE]Related articles

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.

Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C, Rizza RA.

Diabetes. 1997 Mar;46(3):421-32.PMID: 9032098 [PubMed - indexed for MEDLINE]Related articles

Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.

Chung JW, Suh KI, Joyce M, Ditzler T, Henry RR.

Diabetes Care. 1995 May;18(5):666-73.PMID: 8586004 [PubMed - indexed for MEDLINE]Related articles

Assessment of hepatic insulin action in obese type 2 diabetic patients.

Staehr P, Hother-Nielsen O, Levin K, Holst JJ, Beck-Nielsen H.

Diabetes. 2001 Jun;50(6):1363-70.PMID: 11375337 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.

Meneilly GS, Elliott T.

Diabetes Care. 1999 Jan;22(1):112-8.PMID: 10333911 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.

Torlone E, Britta M, Rambotti AM, Perriello G, Santeusanio F, Brunetti P, Bolli GB.

Diabetes Care. 1993 Oct;16(10):1347-55.PMID: 8269792 [PubMed - indexed for MEDLINE]Related articles

Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.

Del Prato S, Matsuda M, Simonson DC, Groop LC, Sheehan P, Leonetti F, Bonadonna RC, DeFronzo RA.

Diabetologia. 1997 Jun;40(6):687-97.PMID: 9222649 [PubMed - indexed for MEDLINE]Related articles

Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.

Orskov L, Alberti KG, Mengel A, Møller N, Pedersen O, Rasmussen O, Seefeldt T, Schmitz O.

Diabetologia. 1991 Jul;34(7):521-6.PMID: 1916058 [PubMed - indexed for MEDLINE]Related articles

Alterations in glucose metabolism in the elderly patient with diabetes.

Meneilly GS, Dawson K, Tessier D.

Diabetes Care. 1993 Sep;16(9):1241-8.PMID: 8404427 [PubMed - indexed for MEDLINE]Related articles

In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?

Burén J, Lindmark S, Renström F, Eriksson JW.

Metabolism. 2003 Feb;52(2):239-45.PMID: 12601640 [PubMed - indexed for MEDLINE]Related articles

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N.

Diabetes. 2001 Aug;50(8):1844-50.PMID: 11473047 [PubMed - indexed for MEDLINE]Related articlesFree article